Clinical Trial Update: Individualization of Dosage Regimens in Obese Patients: Application to Acyclovir [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial conducted at University Hospital, Toulouse is exploring individualizing acyclovir dosage regimens in obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ACYCLOVIR (Acyclovir)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Obesity | Phase 1 | Status: RECRUITING